Nemaura Medical Inc. (NMRD)
OTCMKTS: NMRD · Delayed Price · USD
0.105
+0.021 (24.26%)
Mar 26, 2024, 4:00 PM EDT - Market open

Nemaura Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016201520142013
Revenue
0.080.500000000
Revenue Growth (YoY)
-84.71%---------
Cost of Revenue
1.550.3400000000
Gross Profit
-1.480.1600000000
Selling, General & Admin
5.66.173.032.772.180.920.520.510.50.2
Research & Development
1.541.561.552.012.30.991.031.030.820.38
Other Operating Expenses
0.98000000000
Operating Expenses
7.147.734.594.784.481.911.551.541.320.59
Operating Income
-9.6-7.57-4.59-4.78-4.48-1.91-1.55-1.54-1.32-0.59
Interest Income
6.416.672.0100.020.090000
Interest Expense
6.416.672.010000000
Other Expense / Income
4.556.672.01--0.02-----
Pretax Income
-14.14-14.24-6.59-4.77-4.45-1.82-1.55-1.54-1.32-0.59
Income Tax
10.96-0.35-0.34-0.610.0200000
Net Income
-25.1-13.89-6.26-4.16-4.45-1.82-1.55-1.54-1.32-0.59
Shares Outstanding (Basic)
2523222118150205202200200
Shares Outstanding (Diluted)
2523222118150205202200200
Shares Change
6.39%4.94%7.10%15.01%-87.95%-26.79%1.62%0.86%--
EPS (Basic)
-1.01-0.59-0.28-0.20-0.25-0.01-0.01-0.01-0.01-0.00
EPS (Diluted)
-1.01-0.59-0.28-0.20-0.25-0.01-0.01-0.01-0.01-0.00
Free Cash Flow
-8.99-7.46-6.83-3.66-3.64-2.18-1.27-1.3-1.531.49
Free Cash Flow Per Share
-0.36-0.32-0.31-0.18-0.20-0.01-0.01-0.01-0.010.01
Gross Margin
-1916.30%31.67%--------
Operating Margin
-12454.23%-1502.35%--------
Profit Margin
-32584.93%-2755.83%--------
Free Cash Flow Margin
-11669.95%-1480.54%--------
EBITDA
-8.17-7.34-4.49-4.72-4.44-1.88-1.53-1.52-1.31-0.58
EBITDA Margin
-10605.65%-1456.74%--------
Depreciation & Amortization
0.440.230.10.050.030.030.020.020.010.01
EBIT
-8.62-7.57-4.59-4.78-4.48-1.91-1.55-1.54-1.32-0.59
EBIT Margin
-11182.18%-1502.35%--------
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.